CPIG
VNRX icon

Chicago Partners Investment Group’s VolitionRx Ltd VNRX Stock Holding History

Chicago Partners Investment Group’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-600
Closed -$1.89K – 1691
2026
Q1 		$1.89K Hold
600
– – ﹤0.01% 1487
2025
Q4 		$3.38K Sell
600
-208
-26% -$1.58K ﹤0.01% 1295
2025
Q3 		$6.87K Sell
808
-78
-9% -$1.04K ﹤0.01% 1215
2025
Q2 		$13K Hold
886
– – ﹤0.01% 1092
2025
Q1 		$9.2K Buy
+886
New +$10.6K ﹤0.01% 930

Other funds holding VNRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

Chicago Partners Investment Group's VNRX Position: Q2 2026 in Review

Chicago Partners Investment Group sold out of VolitionRx Ltd (VNRX) in Q2 2026, closing a stake of 600 shares — an estimated $1.89K sold.

Chicago Partners Investment Group first reported a position in VNRX in Q1 2025 and held it in 5 quarters. The position peaked at $13K in Q2 2025. 19 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

  • Chicago Partners Investment Group reported no remaining VolitionRx Ltd position as of Q2 2026 after selling out during the quarter.
  • Chicago Partners Investment Group sold 600 VolitionRx Ltd shares in Q2 2026, an estimated $1.89K.
  • Chicago Partners Investment Group first reported a position in VolitionRx Ltd in Q1 2025 and held it in 5 quarters.
  • Chicago Partners Investment Group's VolitionRx Ltd position peaked at $13K in Q2 2025.
  • 19 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.